Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase
- PMID: 16024664
- DOI: 10.1124/mol.105.011544
Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase
Abstract
Reactive oxygen species (ROS) are produced by all aerobic cells and have been implicated in the regulation of diverse cellular functions, including intracellular signaling, transcription activation, proliferation, and apoptosis. Salvicine, a novel diterpenoid quinone compound, demonstrates a broad spectrum of antitumor activities. Although salvicine is known to trap the DNA-topoisomerase II (Topo II) complex and induce DNA double-strand breaks (DSBs), its precise antitumor mechanisms remain to be clarified. In this study, we investigated whether salvicine altered the levels of ROS in breast cancer MCF-7 cells and whether these ROS contributed to the observed antitumoral activity. Our data revealed that salvicine stimulated intracellular ROS production and subsequently elicited notable DSBs. The addition of N-acetyl cysteine (NAC), an antioxidant, effectively attenuated the salvicine-induced ROS enhancement and subsequent DNA DSBs. Heat treatment reversed the accumulation of DNA DSBs, and the addition of NAC attenuated the Topo II-DNA cleavable complexes formation and the growth inhibition of salvicine-treated JN394top2-4 yeast cells, collectively indicating that Topo II is a target of the salvicine-induced ROS. On the other hand, when examining the impact of salvicine on DNA repair pathways, we unexpectedly observed that salvicine selectively down-regulated the catalytic subunit of DNA-dependent protein kinase (DNA-PK(CS)) protein levels and repressed DNA-PK kinase activity; both of these effects were attenuated by NAC pretreatment of MCF-7 cells. Finally and most importantly, NAC attenuated salvicine-induced apoptosis and cytotoxicity in MCF-7 cells. These results indicate that apart from its direct actions, salvicine generates ROS that modulate DNA damage and repair, contributing to the comprehensive biological consequences of salvicine treatment, such as DNA DSBs, apoptosis, and cytotoxicity in tumor cells. The finding of salvicine-induced ROS provides new evidence for the molecular mechanisms of this compound. Moreover, the effects of salvicine-induced ROS on Topo II and DNA-PK give new insights into the diverse biological activities of ROS.
Similar articles
-
Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells.Cancer Biol Ther. 2007 Nov;6(11):1794-9. doi: 10.4161/cbt.6.11.4860. Epub 2007 Aug 12. Cancer Biol Ther. 2007. PMID: 18032928
-
Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes.Biochem Pharmacol. 2001 Sep 15;62(6):733-41. doi: 10.1016/s0006-2952(01)00732-8. Biochem Pharmacol. 2001. PMID: 11551518
-
Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling.Mol Cancer Res. 2008 Feb;6(2):194-204. doi: 10.1158/1541-7786.MCR-07-0197. Mol Cancer Res. 2008. PMID: 18314480
-
Salvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation.Acta Pharmacol Sin. 2007 Sep;28(9):1460-5. doi: 10.1111/j.1745-7254.2007.00698.x. Acta Pharmacol Sin. 2007. PMID: 17723179 Review.
-
Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade.Front Oncol. 2022 Jun 1;12:899009. doi: 10.3389/fonc.2022.899009. eCollection 2022. Front Oncol. 2022. PMID: 35719997 Free PMC article. Review.
Cited by
-
Cribrostatin 6 induces death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism.Invest New Drugs. 2011 Aug;29(4):562-73. doi: 10.1007/s10637-010-9390-x. Epub 2010 Feb 20. Invest New Drugs. 2011. PMID: 20169400
-
Naphthalimides induce G(2) arrest through the ATM-activated Chk2-executed pathway in HCT116 cells.Neoplasia. 2009 Nov;11(11):1226-34. doi: 10.1593/neo.09986. Neoplasia. 2009. PMID: 19881958 Free PMC article.
-
New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors.J Mol Histol. 2006 Sep;37(5-7):203-18. doi: 10.1007/s10735-006-9043-8. Epub 2006 Jul 26. J Mol Histol. 2006. PMID: 16868862 Review.
-
Etoposide, an anticancer drug involved in therapy-related secondary leukemia: Enzymes at play.Transl Oncol. 2021 Oct;14(10):101169. doi: 10.1016/j.tranon.2021.101169. Epub 2021 Jul 6. Transl Oncol. 2021. PMID: 34243013 Free PMC article. Review.
-
Rapid Diminution in the Level and Activity of DNA-Dependent Protein Kinase in Cancer Cells by a Reactive Nitro-Benzoxadiazole Compound.Int J Mol Sci. 2016 May 11;17(5):703. doi: 10.3390/ijms17050703. Int J Mol Sci. 2016. PMID: 27187356 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases